It’s been 200 years since the death of Edward Jenner – but how best to celebrate his achievement?

How are the last few years of pharmaceutical industry trends affecting the drug delivery landscape – and what opportunities should we grasp?

Oligonucleotides are a complex but promising new modality in therapeutics. Director of New Modalities at CatSci Nigel Richardson explains why.

A new technology called ASCEND is being using to help pharmaceutical research.

With new vaccines come new challenges – and the need for new tools. Can mass spectrometry solve the problem of impurities?

The International Vaccine Institute’s Youngmi Cho is on a mission to protect communities against diseases of poverty

From resins to buffers to single-use technologies – there are many opportunities to improve downstream processes.

Why modular designs will be the future of advanced therapy manufacturing.

How the thoughtful adoption of new technology can both problem-solve and future- proof critical processes in biomanufacturing

Do investors scrutinize pharma CEOs more closely when they are women?